David Maag

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

Shane Crotty, David Maag, Jamie J. Arnold et al. · Nature Medicine · 2000 · 818 citations

Life Sciences, Microbiology, Molecular Biology +12

Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial

Sibylle Loibl, Joyce O’Shaughnessy, Michael Untch et al. · The Lancet Oncology · 2018 · 771 citations

Medicine, Oncology, Pharmacology +14

Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain

Anutosh Chakraborty, Michael A. Koldobskiy, Nicholas T. Bello et al. · Cell · 2010 · 365 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

The Eukaryotic Translation Initiation Factors eIF1 and eIF1A Induce an Open Conformation of the 40S Ribosome

Lori A. Passmore, T.M. Schmeing, David Maag et al. · Molecular Cell · 2007 · 333 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial

Véronique Dièras, Hyo S. Han, Bella Kaufman et al. · The Lancet Oncology · 2020 · 321 citations · Full text

Medicine, Oncology, Pharmacology +10